Treatment of recalcitrant dermatomyositis with efalizumab.

Suppr

超能文献

作者信息

Huber Andrea, Gaffal Evelyn, Bieber Thomas, Tüting Thomas, Wenzel Joerg

出版信息

Acta Derm Venereol. 2006;86(3):254-5. doi: 10.2340/00015555-0058.

DOI:10.2340/00015555-0058

PMID:16710589

Abstract

摘要

相似文献

Treatment of recalcitrant dermatomyositis with efalizumab.

Acta Derm Venereol. 2006;86(3):254-5. doi: 10.2340/00015555-0058.

Relapse of dermatomyositis after 10 years in remission following curative surgical treatment of lung cancer.

J Dermatol. 2005 Apr;32(4):290-4. doi: 10.1111/j.1346-8138.2005.tb00765.x.

Dermatomyositis, clinically presenting with cutaneous ulcers, with histopathologic evidence of perforating collagenosis.

Dermatol Online J. 2016 Dec 15;22(12):13030/qt6qd0q51w.

Physical signs for the general dental practitioner. Case 72. Dermatomyositis.

Dent Update. 2010 Mar;37(2):128.

Successful treatment of severe atopic dermatitis in a child and an adult with the T-cell modulator efalizumab.

Arch Dermatol. 2006 May;142(5):555-8. doi: 10.1001/archderm.142.5.555.

Self-assessment quiz: dermatomyositis.

J Ophthalmic Nurs Technol. 1997 Jul-Aug;16(4):199-200.

Oral erosive lichen planus treated with efalizumab.

Arch Dermatol. 2006 Jun;142(6):680-2. doi: 10.1001/archderm.142.6.680.

Adult dermatomyositis associated with lipodystrophy.

Actas Dermosifiliogr. 2013 Oct;104(8):724-5. doi: 10.1016/j.adengl.2012.07.034. Epub 2013 Aug 17.

Successful treatment of recalcitrant malar rash in a patient with cutaneous lupus erythematosus with efalizumab.

Clin Exp Dermatol. 2008 May;33(3):347-8. doi: 10.1111/j.1365-2230.2007.02648.x. Epub 2008 Jan 14.

The red face: dermatomyositis.

Clin Dermatol. 1993 Apr-Jun;11(2):261-73. doi: 10.1016/0738-081x(93)90062-h.

引用本文的文献

The continuing evolution of targeted therapy for inflammatory skin disease.

Semin Immunopathol. 2016 Jan;38(1):123-33. doi: 10.1007/s00281-015-0524-2. Epub 2015 Sep 30.

Biologics in dermatology: an integrated review.

Indian J Dermatol. 2014 Sep;59(5):425-41. doi: 10.4103/0019-5154.139859.

Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.

Drugs. 2014 Jun;74(9):981-98. doi: 10.1007/s40265-014-0240-6.

Biologics in dermatologic therapy - an update.

Indian J Dermatol. 2009 Jul;54(3):211-20. doi: 10.4103/0019-5154.55627.

Immunomodulatory treatment for dermatomyositis.

Curr Allergy Asthma Rep. 2008 Jul;8(4):348-53. doi: 10.1007/s11882-008-0055-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Treatment of recalcitrant dermatomyositis with efalizumab.

Acta Derm Venereol. 2006;86(3):254-5. doi: 10.2340/00015555-0058.

Relapse of dermatomyositis after 10 years in remission following curative surgical treatment of lung cancer.

J Dermatol. 2005 Apr;32(4):290-4. doi: 10.1111/j.1346-8138.2005.tb00765.x.

Dermatomyositis, clinically presenting with cutaneous ulcers, with histopathologic evidence of perforating collagenosis.

Dermatol Online J. 2016 Dec 15;22(12):13030/qt6qd0q51w.

Physical signs for the general dental practitioner. Case 72. Dermatomyositis.

Dent Update. 2010 Mar;37(2):128.

Successful treatment of severe atopic dermatitis in a child and an adult with the T-cell modulator efalizumab.

Arch Dermatol. 2006 May;142(5):555-8. doi: 10.1001/archderm.142.5.555.

Self-assessment quiz: dermatomyositis.

J Ophthalmic Nurs Technol. 1997 Jul-Aug;16(4):199-200.

Oral erosive lichen planus treated with efalizumab.

Arch Dermatol. 2006 Jun;142(6):680-2. doi: 10.1001/archderm.142.6.680.

Adult dermatomyositis associated with lipodystrophy.

Actas Dermosifiliogr. 2013 Oct;104(8):724-5. doi: 10.1016/j.adengl.2012.07.034. Epub 2013 Aug 17.

Successful treatment of recalcitrant malar rash in a patient with cutaneous lupus erythematosus with efalizumab.

Clin Exp Dermatol. 2008 May;33(3):347-8. doi: 10.1111/j.1365-2230.2007.02648.x. Epub 2008 Jan 14.

The red face: dermatomyositis.

Clin Dermatol. 1993 Apr-Jun;11(2):261-73. doi: 10.1016/0738-081x(93)90062-h.

引用本文的文献

The continuing evolution of targeted therapy for inflammatory skin disease.

Semin Immunopathol. 2016 Jan;38(1):123-33. doi: 10.1007/s00281-015-0524-2. Epub 2015 Sep 30.

Biologics in dermatology: an integrated review.

Indian J Dermatol. 2014 Sep;59(5):425-41. doi: 10.4103/0019-5154.139859.

Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.

Drugs. 2014 Jun;74(9):981-98. doi: 10.1007/s40265-014-0240-6.

Biologics in dermatologic therapy - an update.

Indian J Dermatol. 2009 Jul;54(3):211-20. doi: 10.4103/0019-5154.55627.

Immunomodulatory treatment for dermatomyositis.

Curr Allergy Asthma Rep. 2008 Jul;8(4):348-53. doi: 10.1007/s11882-008-0055-1.